Clinical Trials Browser

Phase 2 × Stomach Neoplasms × Imatinib Mesylate × Clear all

NCT03170180 2022-06-15

Exploratory Study of Drug Sensitivity Prediction Software (IRCR-DReSS) With Patient-derived Tumor Cells of Metastatic Gastric Cancer

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms

NCT00068380 2018-07-11

A Phase II Trial of STI571 in the Treatment of Metastatic Gastric Cancer

Phase 2 Completed

17 enrolled 8 charts

Gastrointestinal

Stomach Neoplasms